Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction.
Headwaters of the zebrafish -- emergence of a new model vertebrate.
Estrogen treatment in multiple sclerosis.
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
New data from Phase 3 studies provide additional evidence supporting treatment effect for oral BG-12 (dimethyl fumarate) in multiple sclerosis
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.
Repurposing drugs for disease modification in multiple sclerosis
Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
New analysis shows Novartis drug Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.
[Assessment of the pain patients with the multiple sclerosis after applying the physiotherapy treatment].
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
[Information processing speed and influential factors in multiple sclerosis].
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Genzyme provides update on U.S. LEMTRADA™ filing
Copaxone

Pages